RecruitingNot ApplicableNCT06860867

PerQdisc Traditional Feasibility Trial.

A Multi-center Traditional Feasibility Trial of the PerQdisc Artificial Implant in Treatment of Single-level Discogenic Back Pain.


Sponsor

Spinal Stabilization Technologies

Enrollment

5 participants

Start Date

Jan 10, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This is a traditional feasibility study (TFS) study to evaluate the safety and effectiveness of the PerQdisc. The study is prospective, multicenter, and open label. After a screening period, qualified participants will be enrolled and treated with the PerQdisc. Patients will not be blinded to their treatment. Participants will then complete the safety follow-up period.


Eligibility

Min Age: 22 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called PerQdisc for people with discogenic low back pain. The study is currently recruiting participants at 8 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPerQdisc

PerQdisc Artificial Implant


Locations(8)

Hope Research Institute

Glendale, Arizona, United States

The CORE Institute

Phoenix, Arizona, United States

HOPE Research Institute

Phoenix, Arizona, United States

HonorHealth Research & Innovation Institute

Scottsdale, Arizona, United States

Axis Spine Center

Coeur d'Alene, Idaho, United States

Indiana Spine Group

Carmel, Indiana, United States

Spine Institute of Louisiana

Shreveport, Louisiana, United States

SonoSpine

Oklahoma City, Oklahoma, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06860867


Related Trials